Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

Pfaller, M.A, Messer, S.A, Hollis, R.J, Jones, R.N, Doern, G.V, Brandt, M.E, Hajjeh, R.A · 1999 · Diagnostic Microbiology and Infectious Disease

Abstract

National surveillance of blood stream infections (BSI) attributable to Candida spp. has been limited to date. Recent studies have suggested in increase in the proportion of BSI attributable to non-Candida albicans species and have also raised concerns regarding the emergence of antifungal resistance among Candida spp. The increased utilization of broad-spectrum antifungal agents and the recognition of Candida spp. as prominent pathogens with the potential for developing antifungal resistance, emphasize the need for ongoing surveillance of antifungal susceptibility patterns. In this investigation trends in species distribution and susceptibility to fluconazole among BSI isolates of Candida spp. referred to our laboratory by United States hospitals were evaluated over the 7-year period from 1992 to 1998. A total of 1579 BSI isolates from more than 50 medical centers were processed. Overall, C. albicans accounted for 52% of isolates followed by C. glabrata (18%), C. parapsilosis (15%), C. tropicalis (11%), and C. krusei (2%). The proportion of BSI isolates that were C. albicans ranged from 45% in 1992 to 60% in 1998. Among the non-C. albicans isolates, C. glabrata succeeded C. parapsilosis as the most common species beginning in 1995. Overall, the susceptibility of all Candida species (C. albicans plus all other species) to fluconazole remained stable (MIC90, 16 micrograms/mL). The fluconazole MIC90 for C. albicans was 0.5-2.0 micrograms/ml for all years studied except 1995 (8.0 micrograms/mL) and was 1.0 microgram/mL overall. The present study suggests a continued prominent role of C. albicans as a cause of BSI, and a constant level of susceptibility of Candida BSI isolates to fluconazole over 7 years. These data should serve as a baseline for future surveillance efforts for anti-fungal agents tested against yeast BSI isolates.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0732-8893(98)00160-6

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 216

Metadata

Authors
Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Doern, G. V., Brandt, M. E., & Hajjeh, R. A.
Affiliations
  • University of Iowa (US)
  • Centers for Disease Control and Prevention (US)
Corresponding author
Pfaller, M.A
Venue
Diagnostic Microbiology and Infectious Disease
Publisher
Elsevier BV
Published
1999-04
Volume
33
Issue
4
Pages
217-222
ISSN
0732-8893 (ISSN-L)
OpenAlex
W2049689302
Cited by
216
References
26
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 6 · 2015: 4 · 2014: 6 · 2013: 8 · 2012: 9
FWCI
12.88
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Diagnostic Microbiology and Infectious Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida species, bloodstream infection, fluconazole susceptibility, antifungal resistance, Candida albicans, non-albicans Candida, Candida glabrata, Candida parapsilosis, Candida tropicalis, Candida krusei, minimum inhibitory concentration
MeSH terms
Antifungal Agents, Candida, Candidiasis, Humans, Microbial Sensitivity Tests, United States, Fluconazole, Fungemia, Sentinel Surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. https://app.cochat.ai/papers/10.1016/s0732-8893(98)00160-6
The paper
Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Doern, G. V., Brandt, M. E., & Hajjeh, R. A. (1999). Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagnostic Microbiology and Infectious Disease. https://doi.org/10.1016/s0732-8893(98)00160-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.